Houston, TX · Founded 2015 · Privately Held (backing)
Developer of a biomedical engineering technology designed to improve the quality and length of life for dialysis patients. VenoStent is based in Houston, TX and was founded in 2015. It has raised $22.8 million across 2 recorded rounds; the latest was a $10 million early-stage round in Apr 2026.
Last price · $/share
—
Implied valuation
—
Total raised
$22.8M
Last round
Early Stage VC
Apr 2026
Cap table — not yet on record
VenoStent's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of VenoStent with a free account
·The complete investor list: 30 names
·Watch VenoStent: the Monday email on marks, rounds and moves